Director Steven H. Collis buys 3,000 Elevance Health (ELV) shares in market trade

Rhea-AI Filing Summary

Elevance Health director Steven H. Collis reported an open-market purchase of common stock. On March 5, 2026, he bought 3,000 shares of Elevance Health at an average price of $289.84 per share. Following this transaction, he directly owns 3,639 common shares of the company.

Insider Trade Summary

Net Buyer: 3,000 shares ($869,520)

Net Buy 1 txn

Insider COLLIS STEVEN H

Role Director

Bought 3,000 shs ($870K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	3,000	$289.84	$870K

Holdings After Transaction: Common Stock — 3,639 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COLLIS STEVEN H

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS IN 46204

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		P		3,000	A	$289.84	3,639	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Elevance Health (ELV) disclose for Steven H. Collis?

Elevance Health disclosed that director Steven H. Collis purchased 3,000 shares of common stock in an open-market transaction. This buy was reported on a Form 4 and reflects a direct increase in his personal share ownership in the company.

How many Elevance Health (ELV) shares did Steven H. Collis buy and at what price?

Steven H. Collis bought 3,000 Elevance Health common shares at an average price of $289.84 per share. This open-market purchase indicates he committed a substantial dollar amount to increase his direct equity stake in the company.

What is Steven H. Collis’s total Elevance Health (ELV) share ownership after this Form 4 trade?

After the reported transaction, Steven H. Collis directly owns 3,639 shares of Elevance Health common stock. This figure reflects his holdings immediately following the 3,000-share open-market purchase disclosed in the Form 4 filing.

Was the recent Elevance Health (ELV) insider transaction a buy or a sell?

The recent insider transaction by director Steven H. Collis was a buy. The Form 4 shows an open-market purchase of 3,000 Elevance Health common shares, not a sale or disposition of previously held stock.

What transaction code was used for Steven H. Collis’s Elevance Health (ELV) trade?

The transaction was reported with code “P,” which indicates a purchase in the open market or a private transaction. In this case, it corresponds to Steven H. Collis’s open-market acquisition of 3,000 shares of Elevance Health common stock.

Is Steven H. Collis’s ownership in Elevance Health (ELV) direct or indirect after this trade?

His ownership is reported as direct following the trade. The Form 4 lists the nature of ownership as direct, meaning the 3,639 Elevance Health common shares are held in his own name rather than through a separate entity or trust.